Legal Representation
Attorney
Kaitlyn M. Garvin
USPTO Deadlines
Next Deadline
2110 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20251021)
Due Date
October 21, 2031
Grace Period Ends
April 21, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 21, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 21, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 2, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 2, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 27, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 29, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 9, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 8, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 8, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 5, 2025 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jun 23, 2025 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 14, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Jun 14, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Apr 15, 2025 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Apr 14, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 9, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 28, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 28, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 20, 2025 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Chemical products in the nature of chemicals for use in industry and science; raw methylene blue for scientific or research use; chemical additives for use in manufacture of pharmaceuticals; proteins in raw material form for scientific and medical research; proteins used in manufacturing processes; chemical additives, namely, emulsifiers, vitamins, antioxidants, additives, emollients and proteins for manufacture of cosmetics; plant hormones being phytohormones; vitamins for manufacturing pharmaceutical products; stabilizing chemical agents, namely, enzyme stabilizers for vitamins
Class 005
Clinical medical reagents; synthetic peptides for the treatment of blood poisoning for pharmaceutical use; medicines to treat conditions of the leg, hoof, ear, nose and throat for animals; vitamins for animals; medicated foams, oils, lotions, creams, balms, ointments, gels and milks for the treatment of skin for pharmaceutical, medical and veterinary use; phytotherapy preparations for medical use; vitamins and vitamin preparations; pharmaceutical diagnostic preparations for medical purposes for marking tissues by injection in surgery and in internal medicine; chemical products, namely, surgical dyes for medical use for marking tissues by injection in surgery and in internal medicine; injectable pharmaceutical solutions for use as radio-isotope markers for diagnostic use in surgical procedures; drug delivery agents in the form of vials in the nature of ampoules sold filled with injectable pharmaceutical solutions that facilitate delivery of pharmaceutical preparations; pre-filled syringes sold filled with antidotes for medical and clinical use and sold filled with injectable pharmaceutical, namely, surgical dyes for marking tissues by application in surgery and internal medicine; methylene blue to treat methemoglobinemia for medical use; methylene blue solutions, namely, surgical dyes for medical use; indigo carmine, namely, surgical dyes for medical use; indigo cumin solutions, namely, surgical dyes for medical use
Additional Information
Design Mark
The mark consists of the stylized wording "PROVEPHARM" in dark blue with the letters "V" and "A" in light blue with the "A" missing the bar. The stylized wording "ACT TO IMPROVE LIFE" in light blue appears above "PHARM". An incomplete circle featuring various geometric shapes in various shades of light blue and dark blue starts above the letter "V" and continues below the "V" to the bottom of the letter "A".
Color Claim
The color(s) light blue and dark blue are claimed as a feature of the mark.
Pseudo Mark
ACT TO IMPROVE LIFE PROVE PHARM
Classification
International Classes
001
005